Abstract
The chemistry, immunochemistry, and immunology of the mycobacterial fatty acid esters of sugars and of sulfated sugars have found their principal focus in the simple nonreducing disaccharide α,α-trehalose, i.e., α-D-glucopyranosyl-α-D-glucopyranoside (1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adam, A., Senn, M., Vilkas, E., and Lederer, E., 1967, Spectrométrie de masse de glycolipides. 2. Diesters de tréhalose naturels et synthétiques, Eur. J. Biochem. 2: 460.
Aebi, A., Asselineau, J., and Lederer, E., 1953, Sur les lipides de la souche humaine “Brévannes” de Mycobacterium tuberculosis, Bull. Soc. Chim. Biol. 35: 661.
Anacker, R. L., Matsumoto, J., Ribi, E., Smith, R. F., and Yamamoto, K., 1973, Enhancement of resistance to tuberculosis by purified components of mycobacterial lipid fractions, J. Infect. Dis. 127: 357.
Anderson, R. J., 1940, The chemistry of the lipids of tubercle bacilli, The Harvey Lecturers 35: 271.
Arnarp, J., and Lönngren, J., 1978, Alkylation of carbohydrates with alkyl trifluoromethanesulfonates, Acta. Chem. Scand. B32: 465.
Artman, M., Bekierkunst, A., and Goldenberg, I., 1964, Tissue metabolism in infection: Biochemical changes in mice treated with cord factor, Arch. Biochem. Biophys. 105: 80.
Asselineau, C., and Asselineau, J., 1978, Trehalose-containing glycolipids, Prog. Chem. Fats Other Lipids 16: 59.
Asselineau, C. P., and Montrozier, H. L., 1976, Étude du processus de biosynthèses des acides phléiques, acides polyinsaturés synthetisés par Mycobacterium phlei, Eur. J. Biochem. 63: 509.
Asselineau, C., Montrozier, H., and Promé, J. C., 1969, Présence d’acides polyinsaturés dans une bactérie: Isolement, à partir des lipides de Mycobacterium phlei, d’acide hexatriacontapentaène-4,8,12,16,20, Coigne et d’acides analogues, Eur. J. Biochem. 10: 580.
Asselineau, C. P., Montrozier, H. L., Promé, J.-C., Savagnac, A. M., and Welby, M., 1972, Étude d’un glycolipide polyinsaturé synthétisé par Mycobacterium phlei, Eur. J. Biochem. 28: 102.
Asselineau, C., Clavel, S., Clérment, F., Daffé, M., David, H., Lanéelle, M. A., and Promé, J. C., 1981, Constituants lipidiques de Mycobacterium leprae isolé de tatou infecté expérimentalment, Ann. Microbiol. Inst. Pasteur 132 (A): 19.
Asselineau, J., 1966, Bacterial Lipids, Holden-Day, San Francisco.
Asselineau, J., and Kato, M., 1973, Chemical structure and biochemical activity of cord factor analogs. II. Relationships between activity and stereochemistry of the sugar moiety, Biochimie 55: 559.
Asselineau, J., and Kato, M., 1975, Relationships between chemical structure and biochemical activity of trehalose-6,6’-dimycolate (cord factor) of Mycobacterium tuberculosis, Jpn. J. Med. Sci. Biol. 28: 94.
Asselineau, J., Durand, E., Lanéèlle, G., Rouanet, J-M., and Tocanne, J-F., 1981, Structure—activity relationships of wall glycolipids of mycobacteria and corynebacteria, in Actinomycetes Zbl. Bakt. Suppl. 11 ( K. P. Schaal and G. Pulverer, eds.), pp. 407–414, Fischer Verlag, Stuttgart.
Azuma, I., and Yamamura, Y., 1962, Studies on the toxic substances isolated from mycobacteria. I. Toxic glycolipids of Mycobacterium fortuitum and atypical mycobacteria strain P16, J. Biochem. 52: 82.
Azuma, I., and Yamamura, Y., 1963, Studies on the firmly bound lipids of human Tubercle bacillus. II. Isolation of arabinose mycolate and identification of its chemical structure, J. Biochem. 53: 275.
Azuma, I., Ribi, E., Meyer, T. J., and Zbar, B., 1974, Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and component P3, J. Natl. Cancer Inst. 52: 95.
Barclay, W. R., Anacker, R., Brehmer, W, and Ribi, E., 1967, Effects of oil-treated mycobacterial cell walls on the organs of mice, J. Bacteriol. 94: 1736.
Barksdale, L., and Kim, K-S., 1977, Mycobacterium, Bacteriol. Rev. 41: 217.
Barrow, W. W., and Brennan, P. J., 1982, Immunogenicity of the type-specific C-mycoside glycopeptidolipids of mycobacteria, Infect. Immun. 36: 676.
Bartlett, G. L., and Zbar, B., 1972, Tumor-specific vaccine containing Mycobacterium bovin and tumor cells: Safety and efficacy, J. Natl. Cancer Inst. 48: 1709.
Bast, R. C., Jr., Bast, B. S., and Rapp, H. J., 1976, Critical review of previously reported animal studies of tumor immunotherapy with nonspecific immunostimulants. International Conference on Immunotherapy of Cancer, Ann. NY Acad. Sci. 277: 60.
Bekierkunst, A., 1968, Acute granulomatous response produced in mice by trehalose-6,6’-dimycolate, J. Bacteriol. 96: 958.
Bekierkunst, A., and Artman, M., 1966, Tissue metabolism in infection: DPNase activity, DPN levels, and DPN-linked dehydrogenases in tissues from normal and tuberculosis mice, Am. Rev. Respir. Dis. 86: 832.
Bekierkunst, A., Levij, I. S., Yarkoni, E., Vilkas, E., Adam, A., and Lederer, E., 1969, Granuloma formation induced in mice by chemically defined mycobacterial fractions,/ Bacteriol. 100: 95.
Bekierkunst, A., Levij, I. S., Yarkoni, E., Vilkas, E., and Lederer, E., 1971, Suppression of urethane-induced lung adenomas in mice treated with trehalose-6,6’-dimycolate (cord factor) and living bacillus Calmette—Guérin, Science 174: 1240.
Bekierkunst, A., Wang, L., Toubiana, R., and Lederer, E., 1974, Immunotherapy of cancer with nonliving BCG and fractions derived from mycobacteria: Role of cord factor (trehalose-6,6’dimycolate) in tumor regression, Infect. Immun. 10: 1044.
Birch, G., and Richardson, A. C., 1970, Chemical modification of trehalose. Part II. Synthesis of the galacto analogue of trehalose, J. Chem. Soc. 1970: 749.
Bloch, H., 1950, Studies on the virulence of tubercle bacilli. Isolation and biological properties of a constituent of virulent organisms, J. Exp. Med. 91: 197.
Bloch, H., and Noll, H., 1955, Studies on the virulence of tubercle bacilli. The effect of cord factor on murine tuberculosis, Br. J. Exp. Pathol. 36: 8.
Bottle, S., and Jenkins, I. A., 1984, Improved synthesis of “cord factor” analogues,/ Chem. Soc. Chem. Commun. 1984: 385.
Bouveng, H., Lindberg, B., and Theander, O., 1957, New synthesis of 4-O-methyl-D-glucose, Acta Chem. Scand. 11: 1788.
Bowden, K., Heilbron, I. M., Jones, E. R. H., and Weedon, B. C. L., 1946, Researches on acetylenic compounds. Part I. The preparation of acetylenic ketones by oxidation of acetylenic carbinols and glycols, J. Chem. Soc. 1946: 39.
Bredereck, H., 1930, Zur konstitution des trehalose, Ber 63 (B): 959.
Brennan, P. J., 1984, Antigenic peptidoglycolipids, phospholipids and glycolipids, in The Mycobacteria. A Source Book ( G. P. Kubica and L. G. Wayne, eds.), pp. 467–489, Marcel Dekker, New York.
Brennan, P. J., and Goren, M. B., 1979, Structural studies on the type-specific antigens and lipids of the Mycobacterium avium—Mycobacterium intracellulare—Mycobacterium scrofulaceum serocomplex`Mycobacterium intracellulare serotype 9, J. Biol. Chem. 254: 4205.
Brennan, P. J., Aspinall, G. O., and Nam-Shin, J. E., 1981, Structures of the specific oligosaccharides from the glycopeptidolipid antigens of serovars in the Mycobacterium avium—Myobbacterium intracellulare—Mycobacterium scrofulaceum complex, J. Biol. Chem. 256: 6817.
Brocheré-Ferréol, G., and Polonsky, J., 1958, Sur la synthèse de substances à activité de “cord factor.” Synthèses de diesters de tréhalose en position 6,6’, Bull. Soc. Chim. Fr. 1958: 714.
Bruneteau, M., and Michel, G., 1968, Structure d’un dimycolate d’arabinose isolé de Mycobacterium marianum, Chem. Phys. Lipids 2: 229.
Castro, B., Chapleur, Y., and Gross, B., 1973, Sels d’alkyloxytris(dimethyl-amino)phosphonium. IV. Activation selective de l’hydroxyle primaire de quelques hexosides, Bull. Soc. Chim. Fr. 1973: 3034.
Chatterjee, D., Cho, S-N., and Brennan, P. J., 1986, Chemical synthesis and seroreactivity of O-(3,6-di-O-methyl-(3-n-glucopyranosyl)-(I-4)-O-(2,3-di-O-methyl-a-L-rhamnopyranosyl)-(1 + 9)-oxynonanoyl—bovine serum albumin— the leprosy-specific, natural disaccharide octylneoglycoprotein, Carbohydr. Res. 156: 39.
Davidson, L. A., Draper, P., Minnikin, D. E., 1982, Studies on the mycolic acids from the walls of Mycobacterium microti, J. Gen. Microbiol. 128: 823.
Daffé, M., Lanéèlle, M. A., Asselineau, C., Lévy-Frébault, and David, H., 1983, Intéret taxonomique des acides gras des mycobactéries: Proposition d’une méthode d’analyse, Ann. Microbiol. Inst. Pasteur 134 (B): 241.
Daffé, M., Lanéèlle, M. A., Roussel, J., and Asselineau, C., 1984, Lipides spécifiques de Mycobacterium ulcerans, Ann. Microbiol. Inst. Pasteur 135 (A): 191.
Dhariwal, K. R., Dhariwal, G., and Goren, M. B., 1984, Observations on the ubiquity of the Mycobacterium tuberculosis sulfatides in mycobacteria, Am. Rev. Respir. Dis. 130: 641.
Dhariwal, K. R., Yang, Y.-M., Fales, H. M., and Goren, M. B., 1987, Detection of trehalose monomycolate in Mycobacterium leprae grown in armadillo tissues, J. Gen. Microbiol. 133: 201.
Draper, P., 1979, Annex 1, protocol 1/79. Report of the enlarged supervisory council meeting for research on the immunology of leprosy, Geneva World Health Organization.
Draper, P., Dobson, G., Minnikin, D. E., and Minnikin, S. M., 1982, The mycolic acids of Mycobacterium leprae harvested from experimentally infected nine-banded armadillos, Ann. Microbiol. (Paris) (Inst. Pasteur) 133B: 39.
Dubos, R. J., 1948, Cellular structures and functions concerned in parasitism, Bacteriol. Rev. 12: 173.
Dubos, R. J. and Middlebrook, G., 1948, Cytochemical reaction of virulent tubercle bacilli, Am. Rev. Tuberc. 58: 698.
Duff, R. B., 1957, Esterification of primary alcoholic groups of carbohydrates with acetic acid: A general reaction, J. Chem. Soc. 1957: 4730.
Durand, E., Welby, M., Lanéèlle, G., and Tocanne, J.-F., 1979e, Phase behaviour of cord factor and related bacterial glycolipid toxins, Eur. J. Biochem. 93: 103.
Durand, E., Gillois, M., Tocanne, J.-F., and Lanéelle, G., 1979b, Property and activity of mycoloyl esters of methyl glucoside and trehalose, Eur. J. Biochem. 94: 109.
Étemadi, A. H., 1964, Techniques microanalytiques d’étude de structure d’esters a-ramifiés ßhydroxylés. Chromatographie en phase vapeur et spectrométrie de masse, Bull. Soc. Chim. Fr. 1964: 1537.
Étemadi, A. H., Miguel, A. M., Lederer, E., and Barbier, M., 1964, Sur la structure des acides amycoliques de Mycobacterium kansasii. Spectromètrie de masse à haute résolution pour des masses de 750 à 1200, Bull. Soc. Chim. Fr. 1964: 3274.
Fieser, L. F., and Fieser, M., 1944, Organic Chemistry, pp. 133–134. D.C. Heath, Boston.
Fieser, M., Fieser, L. F., Toromanoff, E., Hirata, Y., Heymann, H., Tefft, M., and Bhattacharya, S., 1956, Synthetic emulsifying agents, J. Am. Chem. Soc. 78: 2825.
Folch, J., Lees, M., and Sloane-Stanley, G. H., 1957, A simple method for isolation and purification of total lipids from animal tissues, J. Biol. Chem. 226: 497.
Fray, G. I., and Polgar, N., 1956, Synthesis of (+)-2(L):4(L)-dimethyldocosanoic acid, an oxidation product of mycolipenic acid, Chem. Ind. 1956: 23.
Gangadharam, P. R. J., Cohn, M. L., and Middlebrook, G., 1963, Infectivity, pathogenicity and sulpholipid fraction of some Indian and British strains of tubercle bacilli, Tubercle 44: 452.
Gillois, M., Silve, G., Asselineau, J., and Lanéelle, G., 1984, Dicorynomycoloyl trehalose activity: Comparison of the activity of a,a’- and ß,ß’-trehalose derivatives on mitochondrial oxidative phosphorylation, Ann. Microbiol. (Paris) 135 (B): 13.
Goldman, D. S., and Lornitzo, F. A., 1962, Enzyme systems of mycobacteria. The inhibition of the transglycosidase-catalyzed formation of trehalose-6-phosphate, J. Biol. Chem. 237: 3332.
Goren, M. B., 1970a, Sulfolipid I of Mycobacterium tuberculosis, strain H37Rv. Purification and properties, Biochim. Biophys. Acta 210: 116.
Goren, M. B., 1970b, Sulfolipid I of Mycobacterium tuberculosis, strain H37Rv. II. Structural studies, Biochim. Biophys. Acta 210: 127.
Goren, M. B., 1971, Mycobacterial sulfolipids: Spontaneous desulfation, Lipids 6:40. Goren, M. B., 1972, Mycobacterial lipids: Selected topics, Bacteriol. Rev. 36: 33.
Goren, M. B., 1975, Cord factor revisited: A tribute to the late Dr. Hubert Bloch, Tubercle 56: 65.
Goren, M. B., 1977, Phagocyte lysosomes: Interaction with infectious agents, phagosomes, and experimental perturbations in function, Annu. Rev. Microbiol. 31: 507.
Goren, M. B., 1982, Immunoreactive substances of mycobacteria, Am. Rev. Respir. Dis. 125 (pt. 2): 50.
Goren, M. B., 1984, Biosynthesis and structures of phospholipids and sulfatides, in The Mycobacteria, A Source Book ( G. P. Kubica and L. G. Wayne, eds.), pp. 379–415. Marcel Dekker, New York.
Goren, M. B., and Brennan, P. J., 1979, Mycobacterial lipids: Chemistry and biologic activities, in Tuberculosis ( G. P. Youmans, ed.), pp. 63–193, W. B. Saunders, Philadelphia.
Goren, M. B., and Brokl, 0., 1974, Separation and purification of cord factor (6,6’-dimycoloyl trehalose) from wax C or from mycolic acids, Recent Results Cancer Res. 47: 251.
Goren, M. B., and Jiang, K.-S., 1979, Pseudo cord factors: Derivatives of a-n-glucopyranuronosyl (1–1) a-D-glucopyranuronoside, Chem. Phys. Lipids 25: 209.
Goren, M. B., and Jiang, K.-S., 1980, (a-D-Glucopyranosyluronic acid) (a-D-glucopyranosiduronic acid) and simple derivatives, Carbohydr. Res. 79: 225.
Goren, M. B., and Kochansky, M., 1973, The stringent requirement for electrophiles in the facile solvolytic hydrolysis of neutral sulfate ester salts, J. Org . Chem. 38: 3510.
Goren, M. B., and Toubiana, R., 1979, A facile permethylation of cord factor, Biochim. Biophys. Acta 574: 64.
Goren, M. B., Brokl, 0., Das, B. C., and Lederer, E., 1971, Sulfolipid I of Mycobacterium tuberculosis strain H37Rv. Nature of the acyl substituents, Biochemistry 10: 72.
Goren, M. B., Brokl, 0., and Schaefer, W. B., 1974a, Lipids of putative relevance to virulence in Mycobacterium tuberculosis: Correlation of virulence with elaboration of sulfatides and strongly acidic lipids, Infect. Immun. 9: 142.
Goren, M. B., Brokl, 0., and Schaefer, W. B., 1974b, Lipids of putative relevance to virulence in Mycobacterium tuberculosis: Phthiocerol dimycocerosate and the attenuation indicator lipid, Infect. Immun. 9: 150.
Goren, M. B., Brokl, 0., Roller, P., Fales, H. M., and Das, B. C., 1976a, Sulfatides of Mycobacterium tuberculosis: The structure of the principal sulfatide (SL-I), Biochemistry 15: 2728.
Goren, M. B., Hart, P. D:, Young, M. R., and Armstrong, J. A., 19766, Prevention of phagosomelysosome fusion in cultured macrophages by sulfatides of Mycobacterium tuberculosis, Proc. Natl. Acad. Sci. USA 73: 2510.
Goren, M. B., Das, B. C., and Brokl, O., 1978, Sulfatide III of Mycobacterium tuberculosis strain H37Rv, Nouv. J. Chim. 2: 379.
Goren, M. B., Brokl, 0., and Roller, P., 1979, Cord factor (trehalose-6,6’-dimycolate) of in vivo-derived Mycobacterium lepraemurium, Biochim. Biophys. Acta 574: 70.
Goren, M. B., Grange, J. M., Aber, V. R., Allen, B. S., and Mitchison, D. A., 1982, Role of lipid content and hydrogen peroxide susceptibility in determining the guinea-pig virulence of Mycobacterium tuberculosis, Br. J. Exp. Pathol. 63: 693.
Goren, M. B., Vatter, A. E., and Fiscus, J., 1987, Polyanionic agents as inhibitors of phagosomelysosome fusion in cultured macrophages: Evolution of an alternative interpretation, J. Leukocyte Biol. 41: 111.
Grand-Perret, T., Lepoivre, M., Petit, J.-F., and Lemaire, G., 1986, Macrophage activation by trehalose dimycolate. Requirement for an expression signal in vitro for antitumoral activity; biochemical markers distinguishing primed and fully activated macrophages, Eur. J. Immunol. 16: 332.
Grange, J. M., 1982, The genetics of mycobacteria and mycobacteriophages, in The Biology of Mycobacteria ( C. Ratledge and J. Stanford, eds.), pp. 309–351, Academic, London.
Grange, J. M., Aber, V. R., Allen, B. W., Mitchison, D. A., and Goren, M. B., 1978, The correlation of bacteriophage types of Mycobacterium tuberculosis with guinea-pig virulence and in vitro indicators of virulence, J. Gen. Microbiol. 108: 1.
Gray, G. R., Ribi, E., Granger, D., Parker, R., Azuma, I., and Yamamoto, K., 1975, Immunotherapy of cancer: Tumor suppression and regression by cell walls of Mycobacterium phlei attached to oil droplets, J. Natl. Cancer Inst. 55: 727.
Grochowski, E., Hilton, B. D., Kupper, R. J., and Michejda, C. J., 1982, Mechanism of the triphenylphosphine and diethyl azodicarboxylate induced dehydration reactions (Mitsunobu Reaction). The central role of pentavalent phosphorus intermediates, J. Am. Chem. Soc. 106: 6876.
Hanessian, S., Ponpipom, M. M., and Lavallée, P., 1972, Procedures for the direct replacement of primary hydroxyl groups in carbohydrates by halogen, Carbohydr. Res. 24: 45.
Hough, L., Palmer, A. K., and Richardson, A. C., 1972, Chemical modification of trehalose. Part XI. 6,6’-dideoxy-6,6’-difluoro-a,a-trehalose and its galacto analog, J. Chem. Soc. Perkin I 1972: 2513.
Hunter, R. L., Hunter, R. L., and Bennett, B., 1987, Mycobacterial cord factor kills macrophages by a membrane adhesive mechanism, Abstracts, Annual Meeting Am. Soc. Microbiol. U-22.
Hunter, S. W., and Brennan, P. J., 1981, A novel phenolic glycolipid from Mycobacterium leprae possibly involved in immunogenicity and pathogenicity, J. Bacteriol. 147: 728.
Hunter, S. W., Fujiwara, T., and Brennan, P. J., 1982, Structure and antigenicity of the major specific glycolipid antigen of Mycobacterium leprae, J. Biol. Chem. 257: 15072.
Hunter, S. W., Murphy, R. C., Clay, K., Goren, M. B., and Brennan, P. J., 1983, Trehalosecontaining lipooligosaccharides, J. Biol. Chem. 258: 10481.
Hunter, S. W., Fujiwara, T., Murphy, R. C., and Brennan, P. J., 1984, N-acylkansosamine-A novel N-acylamino sugar from the trehalose-containing lipooligosaccharide antigens of Mycobacterium kansasii, J. Biol. Chem. 259: 9729.
Hunter, S. W., Jardine, I., Yanagihara, D., and Brennan, P. J., 1985, Trehalose-containing lipooligosaccharides from mycobacteria: Structures of the oligosaccharide segments and recognition of a unique N-acylkansosamine-containing epitope, Biochemistry 24: 2798.
Ioneda, T., Lenz, M., and Pudles, J., 1963, Chemical constitution of a glycolipid from C. diphtheria PW-8, Biochem. Biophys. Res. Commun. 13: 110.
Jenkins, I. D., and Goren, M. B., 1986, Improved synthesis of cord factor analogues via the Mitsunobu reaction, Chem. Phys. Lipids 41: 225.
Kamisango, I.-I., Saadat, S., Dell, A., and Ballou, C. E., 1985, Pyruvylated glycolipids from Mycobacterium smegmatis. Nature and location of the lipid components, J. Biol. Chem. 260: 4117.
Kanetsuna, F., Imaeda, T., and Cunto, G., 1969, On the linkage between mycolic acid and arabinogalactan in phenol treated mycobacterial cell walls, Biochim. Biophys. Acta 173: 341.
Kato, M., 1967a, Studies of a biochemical lesion in experimental tuberculosis in mice. VI. Effects of toxic bacterial constituents of tubercle bacilli on oxidative phosphorylation in host cells, Am. Rev. Respir. Dis. 96: 998.
Kato, M., 1967b, Procedure for the preparation of aqueous suspension of cord factor, Am. Rev. Respir. Dis. 96: 553.
Kato, M., 1968, Studies of a biochemical lesion in experimental tuberculosis in mice. VII. Structural and functional damage in mouse liver mitochondria under the toxic action of cord factor, Am. Rev. Respir. Dis. 98: 260.
Kato, M., 1970, Site II-specific inhibition of mitochondrial oxidative phosphorylation by trehalose-6,6’-dimycolate (cord factor) of Mycobacterium tuberculosis, Arch. Biochem. Biophys. 140: 379.
Kato, M., 1972, Antibody formation to trehalose-6,6’-dimycolate (cord factor) of Mycobacterium tuberculosis, Infect. Immun. 5: 203.
Kato, M., and Asselineau, J., 1971, Chemical structure and biochemical activity of cord fator analogs 6,6’-dimycoloyl sucrose and methyl 6-mycoloyl-a-D-glucoside, Eur. J. Biochem. 22: 364.
Kato, M., and Fukushi, K., 1969, Studies of a biochemical lesion in experimental tuberculosis in mice. X. Mitochondrial swelling induced by cord factor in vivo and accompanying biochemical change, Am. Rev. Respir. Dis. 100: 42.
Kato, M., and Goren, M. B., 1974, Synergistic action of cord factor and mycobacterial sulfatides on mitochondria, Infect. Immun. 10: 733.
Kato, M., and Maeda, J., 1974, Isolation and biochemical activities of trehalose-6-monomycolate of Mycobacterium tuberculosis, Infect. Immun. 9: 8.
Kato, M., Tamura, T., Silve, G., and Asselineau, J., 1978, Chemical structure and biochemical activity of cord factor analogs. A comparative study of esters of methyl glucoside and nonhydroxylated fatty acids, Eur. J. Biochem. 87: 497.
Kelly, M. T., 1977, Plasma-dependent chemotaxis of macrophages toward BCG cell walls and the mycobacterial glycolipid Ps, Infect. Immun. 15: 180.
Kierszenbaum, F., and Walz, D. R., 1981, Proliferative responses of central and peripheral rat lymphocytes elicited by cord factor (trehalose-6,6’-dimycolate), Infect. Immun. 33: 115.
Kilburn, J. O., Takayama, K., 1981, Effects of ethambutol on accumulation and secretion of trehalose mycolates and free mycolic acid in Mycobacterium smegmatis, Antimicrob. Agents Chem-other. 20: 401.
Kilburn, J. O., Takayama, K., 1983, Cell-free synthesis of trehalose monomycolate and dimycolate by Mycobacterium smegmatis, in Eighteenth Joint Conference on Tuberculosis, pp. 305–319. U.S.Japan Cooperative Medical Science Program, Bethesda.
Kilburn, J. O., Takayama, K., and Armstrong, E. L., 1982, Synthesis of trehalose dimycolate (cord factor) by a cell-free system of Mycobacterium smegmatis, Biochem. Biophys. Res. Commun. 108: 132.
Kinsky, S. C., and Nicolotti, F. A., 1972, Immunological properties of model membranes, Annu. Rev. Biochem. 46: 49.
Kotani, S., Kitaura, Hirano, T., and Tanaka, A., 1959, Isolation and chemical composition of the cell walls of BCG, Biken J. 2: 129.
Kuhn, R., Trischmann, H., and Low, J., 1955, Zur permethylierung von Zuckern und Glykosiden, Angew. Chem. 67: 32.
Kusaka, T., Kohsaka, K., Fukunishi, Y., and Akimori, H., 1981, Isolation and identification of mycolic acids in Mycobacterium leprae and Mycobacterium lepraemurium, Int. J. Leprosy 49: 406.
Lanéelle, M. A., and Lanéelle, G., 1970, Structure d’acides mycoliques et d’un intermediaire dans la biosynthèse d’acides mycoliques dicarboxyliques, Eur. J. Biochem. 12: 296.
Lanéelle, G., and Tocanne, J. F., 1980, Evidence for penetration in liposomes and in mitochondrial membranes of a fluorescent analogue of cord factor, Eur. J. Biochem. 109: 177.
Leake, E. S., Myrvik, Q. N., and Wright, M. J., 1984, Phagosomal membranes of Mycobacterium bovin BCG-immune alveolar macrophages are resistant to disruption by Mycobacterium tuberculosis H37Rv, Infect. Immun. 45: 443.
Lederer, E., 1976, Cord factor and related trehalose esters, Chem. Phys. Lipids 16: 91.
Lederer, E., 1977, Natural and synthetic immunostimulants related to the mycobacterial cell wall, Med. Chem. V: 257.
Lederer, E., 1979, Cord factor and related synthetic trehalose diesters, Springer Semin. Immunopathol. 2: 133.
Lederer, E., 1984, Chemistry of mycobacterial cord factor and related natural and synthetic trehalose esters, in The Mycobacteria. A Source Book ( G. Kubica and L. G. Wayne, eds.), pp. 361–378, Marcel Dekker, New York.
Lemaire, G., Tenu, J.-P., Petit, J.-F., and Lederer, E., 1986, Natural and synthetic trehalose diesters as immunomodulators, Med. Res. Rev. 6: 243.
Lepoivre, M., Tenu, J-P., Lemaire, G., and Petit, J.-F., 1982, Antitumor activity and hydrogen peroxide release by macrophages elicited by trehalose diesters, J. Immunol. 129: 860.
Liav, A., and Goren, M. B., 1980a, Synthesis of 6,6’-di-O-acylated a,a-trehaloses via 2,3,4,2’,3’,4’-hexa-O-benzyl-a,a-trehalose, Carbohydr. Res. 81: C1.
Liav, A., and Goren, M. B., 1980b, A new synthesis of cord factors and analogs, Chem. Phys. Lipids 27: 345.
Liav, A., and Goren, M. B., 1980c, An improved synthesis of (2,3,4-tri-O-acetyl-a-n-glucopyranosyl)uronic acid (2,3,4-tri-0-acetyl-a-D-glucopyranosid)uronic acid, Carbohydr. Res. 84: 171.
Liav, A., and Goren, M. B., 1982, 3’,6’-anhydro-6-O-corynomycoloyl trehalose: Synthesis and identification as the impurity in synthetic cord factor preparations, Chem. Phys. Lipids 30: 27.
Liav, A., and Goren, M. B., 1983, Synthesis of a-D-mannopyranosyl a-D-mannopyranoside from a,a-trehalose: A route to cord factor analogs, Carbohyrd. Res. 123: C22.
Liav, A., and Goren, M. B., 1984a, Cord-factor analogs: Synthesis of 6,6’-di-O-mycoloyl- and -corynomycoloyl-(a-D-mannopyranosyl a-D-mannopyranoside), Carbohydr. Res. 129: 121.
Liav, A., and Goren, M. B., 1984b, Synthesis of 6–0-mycoloyl and 6-O-corynomycoloyl a,atrehalose, Carbohydr. Res. 125: 323.
Liav, A., and Goren, M. B., 1984c, Sulfatides of Mycobacterium tuberculosis. Synthesis of the core a,a-trehalose 2-sulfate, Carbohydr. Res. 127: 211.
Liav, A., and Goren, M. B., 1984d, Sulfate as a blocking group in alkali-catalyzed permethylation: an alternative synthesis of 3,4,6-tri-O-methyl-D-glucose, Carbohydr. Res. 131: C8.
Liav, A., and Goren, M. B., 1985, Synthesis of 4,6,4’,6’- and 3,6,3’,6’-dianhydro-(a-D-galac-topyranosyl a-D-galactopyranoside), Carbohydr. Res. 141: 323.
Liav, A., and Goren, M. B., 1986, An improved synthesis of 6-O-mycoloyl-and 6-O-corynomycoloyl-a,a-trehalose with observations on the permethylation analysis of trehalose glycolipids, Carbohydr. Res. 155: 229.
Liav, A., Das, B. C., and Goren, M. B., 1981, Diamide pseudo cord-factors: bis-N-acyl derivatives of 6,6’-diamino-6,6’-dideoxy-a,a-trehalose, Carbohydr. Res. 94: 230.
Liav, A., Flowers, H. M., and Goren, M. B., 1984a, Cord-factor analogs: Synthesis of 6,6’-di-Omycoloyl-and -corynomycoloyl-(a-D-galactopyranosyl a-D-galactopyranoside), Carbohydr. Res. 133: 53.
Liav, A., Flowers, H., Blancquaert, A.-M., and Goren, M. B., 1984b, Relation of carbohydrate stereochemistry to toxicity of cord factor: Mycoloylated trehalose diastereoisomers, in Nineteenth Joint Conference on Tuberculosis, pp. 253–262, U.S. Japan Cooperative Medical Science Program, Tokyo.
Liav, A., Goren, M. B., Yang, Y-M., and Fales, H. M., 1986, Synthesis of 4,6-anhydro-6’-Omycoloyl and 4,6-anhydro-6’-O-corynomycoloyl-(a-n-galactopyranosyl a-n-glactopyranoside), Carbohydr. Res. 155: 223.
Lornitzo, F., and Goldman, D. S., 1965, Reversible effect of bicarbonate on the inhibition of mycobacterial and yeast transglucosylase by mycoribnin, J. Bacteriol. 89: 1086.
Macfarlane, R. D., 1983, Californium-252 plasma desorption mass spectrometry, Anal. Chem. 55: 1247A.
Malik, U., Prabhudesai, A. V., Khuller, G. K., and Subrahmanyam, D., 1982, Sulfolipids of mycobacteria, IRCS Med. Sci. Biochem. 10: 910.
McCarthy, C., 1976, Synthesis and release of sulfolipid by Mycobacterium avium during growth and cell division, Infect. Immun. 14: 1241.
McLaughlin, C. A., Bickel, W. D., Kyle, J. S., and Ribi, E., 1978a, Synergistic tumor regressive activity observed following treatment of Line-10 hepatocellular carcinomas with deproteinized BCG cell walls and mutant Salmonella typhimurium glycolipid, Cancer Immunol. Immunother. 5: 45.
McLaughlin, C. A., Ribi, E. E., Goren, M. B., and Toubiana, R., 1978b, Tumor regression induced by defined microbial components in an oil-in-water emulsion is mediated through their binding to oil droplets, Cancer Immunol. Immunother. 4: 109.
Meyer, T. J., Ribi, E., Azuma, I., and Zbar, B., 1974, Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma, J. Natl. Cancer Inst. 52: 103.
Middlebrook, G., Coleman, C. M., and Schaefer, W. B., 1959, Sulfolipid from virulent tubercle bacilli, Proc. Natl. Acad. Sci. USA 45: 1801.
Middlebrook, G., Dubos, R. J., and Pierce, C., 1947, Virulence and morphological characteristics of mammalian tubercle bacilli, J. Exp. Med. 86: 175.
Minnikin, D. E., 1982, Lipids: Complex lipids, their chemistry, biosynthesis and roles, in The Biology of the Mycobacteria, Vol. 1 ( C. Ratledge and J. Stanford, eds.), pp. 95–184, Academic Press, London.
Minnikin, D. E., Dobson, G., Sesardic, D., and Ridell, M., 1985, Mycolipenates and mycolipanolates of trehalose from Mycobacterium tuberculosis, J. Gen. Microbiol. 131: 1369.
Mitchison, D. A., 1963, The infectivity and pathogenicity of tubercle bacilli, Am. Rev. Respir. Dis. 88: 267.
Mitchison, D. A., 1964, The virulence of tubercle bacilli from patients with pulmonary tuberculosis in India and other countries, Bull. Int. Union Tuberc. 35: 287.
Mitsunobu, O., 1981, The use of diethyl azodicarboxylate and triphenylphosphine in synthesis and transformation of natural products, Synthesis 1981: 1.
Mompon, B., Federici, C., Toubiana, R., and Lederer, E., 1978, Isolation and structural determination of a “cord-factor” (trehalose-6,6’-dimycolate) from Mycobacterium smegmatis, Chem. Phys. Lipids 21: 97.
Moore, V. L., Myrvik, Q. N., and Kato, M., 1972, Role of cord factor (trehalose-6,6’-dimycolate) in allergic granuloma formation in rabbits Infect. Immun. 6:5.
Myrvik, Q. N., Leake, E. S., and Wright, M. J., 1984, Disruption of phagosomal membranes of normal alveolar macrophages by the H37Rv strain of Mycobacterium tuberculosis. A correlate of virulence, Am. Rev. Respir. Dis. 129: 322.
Nakamura, M., Itoh, T., Yoshitake, Y., Sengupta, U., and Goren, M. B., 1984, Biochemical characteristics of M. lepraemurium propagated in cell-free liquid medium, Int. J. Lepr. Other Mycobact. Dis. 52 (4 suppl.): 720.
Noll, H., 1956, The chemistry of cord factor, a toxic glycolipid of M. tuberculosis, Ado. Tuberc. Res. 7: 149.
Noll, H., and Bloch, H., 1955, Studies on the chemistry of the cord factor of Mycobacterium tuberculosis, J. Biol. Chem. 214: 251.
Noll, H., Bloch, H., Asselineau, J., and Lederer, E., 1956, The chemical structure of the cord factor of Mycobacterium tuberculosis, Biochim. Biophys. Acta 20: 299.
Numata, F., Nishimura, K., Ishida, H., Ukei, S., Tone, Y., Ishihara, C., Saiki, I., Sekikawa, I., and Azuma, I., 1985, Lethal and adjuvant activities of cord factor (trehalose-6,6’-dimycolate) and synthetic analogs in mice, Chem. Pharm. Bull. 33: 4544.
Ofek, S., and Bekierkunst, A., 1976, Chemotactic responses of leukocytes to cord factor (trehalose-6,6’-dimycolate), J. Natl. Cancer Inst. 57: 1379.
Ohara, T., Shimmyo, Y., Sekikawa, I., Morikawa, K., and Sumikawa, E., 1957, Studies on the cord factor, with special reference to its immunological properties, Jpn. J. Tuberc. 5: 128.
Orbach-Arbouys, S., Tenu, J. P., and Petit, J.-F., 1983, Enhancement of in vitro and in vivo antitumor activity by cord factor (6,6’-dimycolate of trehalose) administered suspended in saline, Int. Arch. Allergy Appl. Immunol. 71: 67.
Pabst, M. J., Gross, J. M., Brozna, J. P., and Goren, M. B., 1987, Inhibition of macrophage activation by sulfatide from Mycobacterium tuberculosis J. Immunol. 140: 643.
Pangborn, M. C., and McKinney, J. A., 1966, Purification of serologically active phosphoinositides of Mycobacterium tuberculosis, J. Lipid Res. 7: 627.
Parant, M., Parant, F., Chedid, L., Drapier, J. C., Petit, J.-F., Wietzerbin, J., and Lederer, E., 1977, Enhancement of nonspecific immunity to bacterial infection by cord factor (6,6’-trehalose dimycolate), J. Infect. Dis. 135: 771.
Parant, M., Audibert, F., Parant, F., Chedid, L., Soler, E., Polonsky, J., and Lederer, E., 1978, Nonspecific immunostimulant activities of synthetic trehalose-6,6’-diesters (lower homologs of cord factor), Infect. Immun. 20: 12.
Polonsky, J., and Lederer, E., 1954, Synthèses de quelques acides mycoliques, Bull. Soc. Chim. Fr. 1954: 504.
Polonsky, J., Ferréol, G., Toubiana, R., and Lederer, E., 1956, Sur le “cord factor” lipide toxique de Mycobacterium tuberculosis. Synthèses de substances à activité de “cord factor” (esters de tréhalose et d’acides ramifiés synthetique), Bull. Soc. Chim. Fr. 1956: 1471.
Polonsky, J., Soler, E., Toubiana, R., Takayama, K., Raju, M. S., and Wenkert, E., 1978a, A carbon-13 nuclear magnetic resonance spectral analysis of cord factors and related substances, Nouv. J. Chimie. 2: 317.
Polonsky, J., Soler, E., and Varenne, J., 19786, Sur la synthèse du cord-factor et de ses analogues, Carbohydr. Res. 65: 295.
Prabhudesai, A. V., Malik, U., and Subrahmanyam, D., 1981, Isolation and purification of sulpholipids of Mycobacterium tuberculosis, H37Rv, Ind. J. Biochem. Biophys. 18: 71.
Promé, J.-C., Lacave, C., Ahibo-Coffy, A., and Savagnac, A., 1976, Separation et étude structurale des espèces moleculaires de monomycolates et de dimycolates de a-n-tréhalose présents chez Mycobacterium phlei, Eur. J. Biochem. 63: 543.
Puzo, G., Tissie, G., Lacave, C., Aurelle, H., and Promé, J.-C., 1978, Structural determination of “cord factor” from a Corynebacterium diphtheriae strain by a combination of mass spectral ionization methods: Field desorption cesium cationization and electron impact mass spectrometry studies, Biomed. Mass Spectrometry 5: 699.
Qureshi, N., Takayama, K., and Ribi, E., 1982, Purification and structural determination of nontoxic lipid A obtained from lipopolysaccharide of Salmonella typhimurium, J. Biol. Chem. 251: 118–208.
Ramathan, V. D., Curtis, J., and Turk, J. L., 1980, Activation of the alternative pathway of complement by mycobacteria and cord factor, Infect. Immun. 29: 30.
Rapp, H. J., 1973, A guinea pig model for tumor immunology. A summary, Israel J. Med. Sci. 9: 366.
Reggiardo, Z., and Middlebrook, G., 1975a, Serologically active glycolipid families from Mycobacterium bovin BCG. I. Extraction, purification and immunologic studies, Am. J. Epidemiol. 100: 469.
Reggiardo, Z., and Middlebrook, G., 1975b, Serologically active glycolipid families from Mycobacterium bovis BCG. II. Serological studies on human sera, Am. J. Epidemiol. 100: 477.
Reggiardo, Z., and Vazquez, E., 1981, Comparison of enzyme-linked immunosorbent assay and hemagglutination test using mycobacterial glycolipids, J. Clin. Microbiol. 13: 1007.
Reggiardo, Z., Aber, V. R., Mitchison, D. A. and Devi, S., 1981, Hemagglutination tests for tuberculosis with mycobacterial glycolipid antigens, Am. Rev. Respir. Dis. 124: 21.
Reisser, D., Jeannin, J.-F., Martin, F., 1984, Effet in vivo et in vitro du dimycolate de trehalose (TDM) sur l’activité tumoricide des macrophages péritonéaux de rats, C.R. Acad. Sc. Paris, t. 298, Ser. III 1984: 181.
Retzinger, G. S., 1984, An experimental model of miliary tuberculosis and diffuse intravascular coagulation, in Proceedings of the Nineteenth Joint Research Conference on Tuberculosis, pp. 295313, U.S.—Japan Cooperative Medical Science Program, Tokyo.
Retzinger, G. S., Meredith, S. C., Takayama, K., Hunter, R. L., and Kezdy, F. J., 1981, The role of surface in the biological activities of trehalose 6,6’-dimycolate, J. Biol. Chem. 256: 8208.
Retzinger, G. S., Meredith, S. C., Hunter, R. L., Takayama, K., and Kezdy, F. J., 1982, Identification of the physiologically active state of the mycobacterial glycolipid trehalose-6,6’-dimycolate and the role of fibrinogen in the biologic activities of trehalose-6,6’-dimycolate mono-layers, J. Immunol. 129: 735.
Ribi, E., Anacker, R. L., Barclay, W. R., Brehmer, W., Middlebrook, G., Milner, K. C., and Tarmina, D. F., 1968, Structure and biological functions of mycobacteria, Ann. NY Acad. Sci. 154: 41.
Ribi, E., Anacker, R. L., Barclay, W. R., Brehmer, W., Harris, S. C., Leif, W. R., and Simmons, J., 1971, Efficacy of mycobacterial cell walls as a vaccine against airborne tuberculosis in the Rhesus monkey, J. Infect. Dis. 123: 527.
Ribi, E., Parker, R., and Milner, K., 1974, Microparticulate gel chromatography accelerated by centrifugal force and pressure, Methods Biochem. Anal. 22: 355.
Ribi, E., Granger, D. L., Milner, K. C., and Strain, S. M., 1975, Tumor regression caused by endotoxins and mycobacterial fractions, J. Natl. Cancer Inst. 55: 1253.
Ribi, E., Milner, K. C., Granger, D. L., Kelly, M. T., Yamamoto, K., Brehmer, W., Parker, R., Smith, R. F., and Strain, S. M., 1976a, Immunotherapy with nonviable microbial components, Ann. NY Acad. Sci. 277: 228.
Ribi, E., Milner, K., Kelly, M. T., Granger, D., Yamamoto, K., McLaughlin, C. A., Brehmer, W., Strain, S. M., Smith, R. F., and Parker, R., 1976b, Structural requirements of microbial agents for immunotherapy of the guinea pig line-10 tumor, in BCG in Cancer Immunotherapy ( G. S. Lamoureux, R. Turcotte, and V. Portelance, eds.), pp. 51–61, Grune and Stratton, New York.
Ribi, E., Takayama, K., Milner, K., Gray, G. R., Goren, M., Parker, R., McLaughlin, C. A., and Kelly, M., 1976c, Regression of tumors by an endotoxin combined with trehalose mycolates of differing structure, Cancer Immunol. Immunother. 1: 265.
Ribi, E., Parker, R., Strain, S. M., Mizuno, Y., Nowotny, A., Von Eschen, K. B., Cantrell, J. L., McLaughlin, C. A., Hwang, K. M., and Goren, M. B., 1979, Peptides as requirement for immunotherapy of the guinea-pig line-10 tumor with endotoxins, Cancer Immunol. Immunother. 7: 43.
Ribi, E., Cantrell, J. L., Nowotny, A., Parker, R., Schwartzman, S. M., Von Eschen, K. B., Wheat, R. W., and McLaughlin, C. A., 1980, Tumor regression caused by endotoxins combined with trehalose dimycolate, in Natural Toxins ( D. Eaker and T. Wadstrom, eds.), pp. 327–335, Pergamon, Oxford.
Ribi, E., Cantrell, J., Schwartzman, S., and Parker, R., 1981, BCG cell wall skeleton, P3, MDP and other microbial components—structure activity studies in animal models, in Augmenting Agents in Cancer Therapy ( E. M. Hersh, ed.), pp. 15–31, Raven, New York.
Ribi, E., Cantrell, J. L., Takayama, K., Qureshi, N., Peterson, J., and Ribi, H. O., 1984, Lipid A and immunotherapy, Rev. Infect. Dis. 6: 567.
Ribi, E., Cantrell, J., and Takayama, K., 1985, A new immunomodulator with potential clinical applications: Monophosphoryl lipid A, a detoxified endotoxin, Clin. Immunol. Newsl. 6: 33.
Richman, S. P., Gutterman, J. U., Hersh, E. M., and Ribi, E. E., 1978, Phase I–II study of intratumor immunotherapy with BCG cell wall skeleton plus P3, Cancer Immunol. Immunother. 5: 41.
Ruco, L. P., and Meltzer, M., 1978, Macrophage activation for tumor cytotoxicity: Increased lymphokine responsiveness of peritoneal macrophages during acute inflammation, J. Immunol. 120: 1054.
Saito, R., Tanaka, A., Sugiyama, K., and Kato, M., 1975, Cord factor not toxic in rats, Am. Rev. Respir. Dis. 112: 578.
Saito, R., Tanaka, A., Sugiyama, K., Azuma, I., Yamamura, Y., Kato, M., and Goren, M. B., 1976, Adjuvant effect of cord factor, a mycobacterial lipid, Infect. Immun. 13: 776.
Saito, R., Nagao, S., Sugiyama, K., and Tanaka, A., 1977, Adjuvanticity (immunity-inducing property) of cord factor in mice and rats, Infect. Immun. 16: 725.
Sasaki, A., and Takahashi, Y., 1974, Activité serologiqne des phospholipides purifiés de Mycobacterium tuberculosis, C. R. Soc. Biol. (Paris) 168: 626.
Sathyamoorthy, N., Qureshi, N., and Takayama, K., 1986, Enzymatic exchange of mycolic acid in Mycobacterium smegmatis involving free trehalose and trehalose-6-monomycolate, Fed. Proc. 45: 1823.
Schaefer, W. B., 1965, Serologic identification and classification of the atypical mycobacteria by their agglutination, Am. Rev. Respir. Dis. 92 (suppl.): 85.
Schaefer, W. B., 1980, Serological identification of atypical mycobacteria, in Methods in Micro- biology ( T. Bergan and J. R. Norris, eds.), Vol. 13, pp. 324–344, Academic, London.
Schwartzman, S. M., Cantrell, J. L., Ribi, E., and Ward, J., 1984, Immunotherapy of equine sarcoid with cell wall skeleton (CWS)-trehalose dimycolate (TDM) biologic, Equine Pract. 6: 13.
Seggev, J., Goren, M. B., Carr, R. I., and Kirkpatrick, C. H., 1982, The pathogenesis of interstitial and hemorrhagic pneumonitis induced by mycobacterial trehalose dimycolate, Am. J. Pathol. 106: 348.
Seggev, J. S., Goren, M. B., and Kirkpatrick, C. H., 1984a, The pathogenesis of trehalose dimycolate-induced interstitial pneumonitis, Cell. Immunol. 85: 428.
Seggev, J. S., Kirkpatrick, C. H., Goren, M. B., 1984b, Interstitial pneumonitis induced by trehalose dimycolate. II. Reserpine prevents formation of lesions, Am. Rev. Respir. Dis. 129: 840.
Senn, M., Ioneda, T., Pudles, J., and Lederer, E., 1967, Spectrométrie de masse de glycolipids. I. Structure du “cord factor” de Corynebacterium diphtheriae, Eur. J. Biochem. 1: 353.
Sharma, A., Hag, A., Ahmad, S., and Lederer, E., 1985, Vaccination of rabbits against Entamoeba histolytica with aqueous suspensions of trehalose-dimycolate as the adjuvant, Infect, Immun. 48: 634.
Shimakata, T., Iwaki, M., and Kusaka, T., 1984, In vitro synthesis of mycolic acids by the fluffy layer fraction of Bacterionema matruchotii, Arch. Biochem. Biophys. 229: 329.
Shimakata, T., Tsubokura, K., Kusaka, T., and Shizukuishi, K.-I., 1985, Mass spectrometric identification of the trehalose 6-monomycolate synthesized by the cell-free system of Bacterionema matruchotii, Arch. Biochem. Biophys. 238: 497.
Silva, C., and Faccioli, L. H., 1988, Infect. Immunol. 56: 3067.
Ställberg-Stenhagen, S., 1954, Optically active higher aliphatic compounds. XII trans -2,5-odimethyl-A23-heneicosenoic acid and trans-2,4 D-dimethyl-A2.3-heneicosenoic acid, Ark. Kemi 6: 537.
Strain, S. M., Toubiana, R., Ribi, E., and Parker, R., 1977, Separation of the mixture of trehalose-,6,6’-dimycolates comprising the mycobacterial glycolipid fraction, “P3,” Biochem. Biophys. Res. Commun. 77: 449.
Sukumar, S., Hunter, J. T., Yarkoni, E., Rapp, H. J., Zbar, B., and Lederer, E., 1981, Efficacy of mycobacterial components in the immunotherapy of mice with pulmonary tumor deposits, Cancer Immunol. Immunother. 11: 125.
Suter, E., and Kirsanow, E. M., 1961, Hyperreactivity to endotoxin in mice infected with mycobacteria. Induction and elicitation of the reactions, Immunol. 4: 354.
Takahashi, Y., and Ono, K., 1961, Study of the passive hemagglutination reaction by the phosphatides of M. tuberculosis. I. The reaction and its specificity, Am. Rev. Respir. Dis. 83: 381.
Takayama, K., 1985, Enzymatic transfer of mycolic acid to trehalose from a new mycobacterial lipid to form the trehalose mycolates, in Proceedings of the Twentieth Joint Conference on Tuberculosis, pp. 9–20, U.S.—Japan Cooperative Medical Science Program, Bethesda.
Takayama, K., and Armstrong, E. L., 1976, Isolation, characterization, and function of 6-mycolyl-6’-acetyltrehalose in the H37 Ra strain of Mycobacterium tuberculosis, Biochemistry 15: 441.
Takayama, K., and Qureshi, N., 1984, Structure and synthesis of lipids, in The Mycobacteria, A Source Book, Part A ( G. P. Kubica and L. G. Wayne, eds.), pp. 315–344, Marcel Dekker, New York.
Takayama, K., and Sathyamoorthy, N., 1986, Isolation, purification and characterization of trehalose mycolytransferase from Mycobacterium smegmatis, in Proceedings of the Twenty-first Joint Research Conference on Tuberculosis, pp. 69–79, U.S.—Japan Cooperative Medical Science Program, Osaka.
Takayama, K., Wang, L., and David, H. L., 1972, Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis, Antimicrob. Agents Chemother. 2: 29.
Takayama, K., Wang, L., and Merkal, R. S., 1973, Scanning electron microscopy of the H37Ra strain of Mycobacterium tuberculosis exposed to isoniazid, Antimicrob. Agents Chemother. 4: 62.
Takayama, K., Qureshi, N., Raetz, C. R. H., Ribi, E., Peterson, J., Cantrell, J. L., Pearson, F. C., Wiggins, J., and Johnson, A. G., 1984, Influence of fine structure of lipid A on limulus amebocyte lysate clotting and toxic activities, Infect. Immun. 45: 350.
Tarelli, E., Draper, P., and Payne, S., 1984, Structure of the oligosaccharide component of a serologically active phenolic glycolipid isolated from Mycobacterium leprae, Carbohydr. Res. 131: 346.
Tereletsky, M. J., and Barrow, W. W., 1983, Postphagocytic detection of glycopeptidolipids associated with superficial L layer of Mycobacterium intracellulare, Infect. Immun. 41: 1312.
Tocanne, J.-F., 1975, Sur une nouvelle voie de synthèse du cord-factor glycolipide toxique de Mycobacterium tuberculosis (esters du trehalose et d’acides gras a-ramifiés, 13-hydroxylés), Carbohydr. Res. 44: 301.
Toubiana, R., Toubiana, M.J., Das, B. C., and Richardson, A. C., 1973, Synthèse d’analogues du cord-factor. I. Étude de l’esterification selective du tréhalose par le chlorure de para-toluene sulfonylé. Mise en evidence d’un ester dissymetrique le 2,6-ditosylate de tréhalose, Biochimie 55: 569.
Toubiana, R., Das, B. C., Defaye, J., Mompon, B., and Toubiana, M.J., 1975, Étude du cord-factor et de ses analogues. III. Synthèse du cord-factor (6,6’-di-O-mycoloyl-a,a-tréhalose) et du 6,6’-di-O-palmitoyl-a,a-tréhalose, Carbohydr. Res. 44: 308.
Toubiana, R., Pizza, C., Chapleur, Y., and Castro, B., 1978, Étude du cord-factor et de ses analogues. IV. Preparation du di-O-corynomycoloyl-6,6’-a,a-tréhalose par l’intermediaire du bisel d’alkyloxytris (dimethyl-amino) phosphonium (ATDP), J. Carbohydr. Nucleosides Nucleotides 5: 127.
Tsukamura, M., and Mizuno, S., 1986, Test for sulfolipid formation from [35S]sulfate as an aid to differentiate mycobacteria from Rhodococci and Nocardiae, Microbiol. Immunol. 30: 589.
Tsukamura, M., Mizuno, S., and Toyama, H., 1984, Differentiation of mycobacterial species by investigation of petroleum ether-soluble sulfolipids using thin layer chromatography after incubation with [35S]sulfate, Microbiol. Immunol. 28: 965.
Vilkas, E., and Markovits, J., 1968, Isolément d’un digalactoside et d’un mycolate de diarabinoside à partir de cires D d’une souche humaine virulente de Mycobacterium tuberculosis, FEBS Lett. 2: 20.
Vilkas, E., Adam, A., and Senn, M., 1968, Isolément d’un nouveau type de diester de tréhalose à partir de Mycobacterium fortuitum, Chem. Phys. Lipids 2: 11.
Von Itzstein, M., and Jenkins, I. D., 1983, The mechanism of the Mitsunobu reaction. II. Dialkoxytriphenylphosphoranes, Aust. J. Chem. 36: 557.
Vosika, G. J., and Gray, G. R., 1983, Phase I study of i.v. mycobacterial cell wall skeleton and cell wall skeleton combined with trehalose dimycolate, Cancer Treatm. Rep. 67: 785.
Vosika, G., Giddings, C., and Gray, G. R., 1984a, Phase I study of intravenous mycobacterial cell wall skeleton and trehalose dimycolate attached to oil droplets, J. Biol. Resp. Mod. 3: 620.
Vosika, G., Barr, J. C., and Gilbertson, D., 19846, Phase-I study of intravenous modified lipid A, Cancer Immunol. Immunother. 18: 107.
Walker, R. W., Promé, J.-C., and Lacave, C. S., 1973, Biosynthesis of mycolic acids. Formation of a C32 ß-keto ester from palmitic acid in a cell-free system of Corynebacterium diphtheriae, Biochim. Biophys. Acta 326: 52.
Walker, R. W., Promé, J. C., and Lacave, C., 1973, Mycolic acid biosynthesis: Formation of the ßketo precursor of corynomycolic acid in a cell free system by extracts of Corynebacterium diphtheriae, in Proceedings, Eighth Joint Conference on Tuberculosis, pp. 261–278, U.S. Japan Cooperative Medical Science Program, New Orleans.
Wang, L., and Takayama, K., 1972, Relationship between the uptake of isoniazid and its action on in vivo mycolic acid synthesis in Mycobacterium tuberculosis, Antimicrob. Agents Chemother. 2: 438.
Winder, F. G., 1982, Mode of action of the antimycobacterial agents and associated aspects of the molecular biology of the mycobacteria, in The Biology of the Mycobacteria, Vol. 1 ( C. Ratledge and J. Stanford, eds.), pp. 354–438, Academic, London.
Yarkoni, E., 1982, Factors affecting the antitumor activity of mycobacterial components emulsified in hexadecane, J. Clin. Hematol. Oncol. 12: 105.
Yarkoni, E., and Rapp, H. J., 1977, Granuloma formation in lungs of mice after intravenous administration of emulsified trehalose-6,6’-dimycolate (cord factor): Reaction intensity depends on size distribution of the oil droplets, Infect. Immun. 18: 552.
Yarkoni, E., and Rapp, H. J., 1978, Toxicity of emulsified trehalose-6,6’-dimycolate (cord factor) in mice depends on size distribution of mineral oil droplets, Infect. Immun. 20: 856.
Yarkoni, E., and Rapp, H. J., 1979, Influence of oil and Tween concentrations on enhanced endotoxin lethality in mice pretreated with emulsified trehalose-6,6’-dimycolate (cord factor), Infect. Immun. 24: 571.
Yarkoni, E., Meltzer, M. S., and Rapp, H. J., 1976, Failure of trehalose-6,6’-dimycolate (P3 or cord factor) to enhance endotoxin lethality in mice, Infect. Immun. 14: 1375.
Yarkoni, E., Rapp, H. J., and Zbar, B., 1977a, Immunotherapy of a guinea pig hepatoma with ultrasonically prepared mycobacterial vaccines, Cancer Immunol. Immunother. 2: 143.
Yarkoni, E., Meltzer, M. S., and Rapp, H. J., 19776, Tumor regression after intralesional injection of emulsified trehalose-6,6’-dimycolate (cord factor): efficacy increases with oil concentration, Int. J. Cancer 19: 818.
Yarkoni, E., Rapp, H. J., Polonsky, J., and Lederer, E., 1978, Immunotherapy with an intralesionally administered synthetic cord factor analogue, Int. J. Cancer 22: 564.
Yarkoni, E., Goren, M. B., and Rapp, H. J., 1979a, Regression of a transplanted guinea pig hepatoma after intralesional injection of an emulsified mixture of endotoxin and mycobacterial sulfolipid, Infect. Immun. 24: 357.
Yarkoni, E., Rapp, H. J., Polonsky, J., Varenne, J., and Lederer, E., 19796, Regression of a murine fibrosarcoma after intralesional injection of a synthetic C39 glycolipid related to cord factor, Infect. Immun. 26: 462.
Yoshimoto, K., Wakamiya, T., and Nishikawa, Y., 1982, Chemical and biochemical studies on carbohydrate esters. XIII. Synthesis of 6–0-, 6,6’-di-0-, and 4,6,4’,6’-tetra-O-stearoyl-a,atrehaloses, Chem. Pharm. Bull. 30: 1169.
Zbar, B., Bernstein, I. D., Bartlett, G. L., Hanna, M. G., and Rapp, H.J., 1972, Immunotherapy of cancer: Regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis, J. Natl. Cancer Inst. 49: 119.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media New York
About this chapter
Cite this chapter
Goren, M.B. (1990). Mycobacterial Fatty Acid Esters of Sugars and Sulfosugars. In: Kates, M. (eds) Glycolipids, Phosphoglycolipids, and Sulfoglycolipids. Handbook of Lipid Research, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2516-9_5
Download citation
DOI: https://doi.org/10.1007/978-1-4899-2516-9_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-2518-3
Online ISBN: 978-1-4899-2516-9
eBook Packages: Springer Book Archive